Recipharm

Last updated
Recipharm AB
FormerlyRecip
IndustryPharmaceutical Contract Development and Manufacturing Organisation
Founded Stockholm, Sweden, 1995
Headquarters
Stockholm, Sweden
Key people
Richard Ridinger, Chairman, Marc Funk, CEO, Joaquim Mascaró, CFO
ProductsPharmaceutical products for humans
RevenueSEK 11,069 million (2020)
Number of employees
8,666 (2020)
Website recipharm.com

Recipharm AB is one of the five largest pharmaceutical contract development and manufacturing organizations in the world, with production facilities in Sweden, France, Germany, Italy, Spain, Portugal, India and the UK as well as development sites in Sweden, Israel and the United States. The Swedish-based company employs around 9,000 people and operates over 30 facilities. The company provides pharmaceutical companies around the world with end-to-end development and manufacturing services, including a wide variety of dosage forms. Recipharm was listed on the Stockholm Stock Exchange in April 2014.

Contents

History

Recip 1995-2007

In March 1995, Thomas Eldered and Lars Backsell conducted a management buyout of a Pharmacia solid dose tablet manufacturing facility in Årsta, Stockholm and formed the company “Recip”. The facility had 130 employees and a turnover of SEK 220 million. [1] The company continued to manufacture pharmaceutical products for Pharmacia during a transition period while it also developed its own products. Recip also began providing contract manufacturing services to other pharmaceutical companies.

In 1997, Recip was believed to be the first pharmaceutical company in the world to certify its entire operations according to the ISO 14001 environmental management system. [2] From 1998, the company began to grow by acquiring facilities in Sweden. The brand name “Recipharm” was established in 2001 for the growing contract manufacturing part of Recip's business. In 2007, the Recip part of the business and the company's own portfolio were divested to Meda. [3]

Recipharm 2007-present

Following the sale of Recip, the company focused on its contract manufacturing business. The capital from the sale of Recip was used to make further acquisitions – initially in Europe and later the US and India. Acquisitions were used to broaden the company's offering and customer base, and to enter new markets.

Recipharm became a public listed company on Nasdaq Stockholm in 2014. [4] Between 2014 and 2019, Recipharm's sales grew by an average of more than 30 per cent annually, including a combination of internal growth and acquisitions.[ citation needed ] In 2020, Recipharm completed its largest acquisition to date. The £505 million takeover of UK-based Consort Medical added around 2,000 employees and ten European facilities to the company, as well as new device capabilities.

In February 2021, Private equity firm EQT acquired Recipharm [5] for $2.1 billion. In March 2021, Mark Funk joined Recipharm as CEO, replacing Thomas Eldered who remains on the board of directors. [5]

The Recipharm International Environmental Award

Recipharm's International Environmental Award is annually awarded for the best environmental performance or environmental innovation within the pharmaceutical industry or academia. [6]

External Recognition

Related Research Articles

<span class="mw-page-title-main">Pharmacia</span> Pharmaceutical and biotechnological company

Pharmacia was a pharmaceutical and biotechnological company in Sweden that merged with the American pharmaceutical company Upjohn in 1995.

<span class="mw-page-title-main">Nasdaq Nordic</span> Swedish-based subsidiary of Nasdaq, Inc.

Nasdaq Nordic is the common name for the subsidiaries of Nasdaq, Inc. that provide financial services and operate marketplaces for securities in the Nordic and Baltic regions of Europe.

<span class="mw-page-title-main">Nasdaq Stockholm</span> Stock exchange located in Stockholm, Sweden

<span class="mw-page-title-main">Investor AB</span> Swedish investment and conglomerate holding company

Investor AB is a Swedish investment and holding company, considered a de facto conglomerate. It was founded in 1916 and is still controlled by the Wallenberg family through its company FAM AB. The company owns a controlling stake in several large Swedish companies, with smaller positions in a number of other firms.

<span class="mw-page-title-main">Atlas Copco</span> Swedish multinational industrial company

Atlas Copco is a Swedish multinational industrial company that was founded in 1873. It manufactures industrial tools and equipment.

Aptalis was a company in the pharmaceutical industry. In January 2014, the company was acquired by Forest Laboratories for $675 million. Through a series of acquisitions, the company is now a contract development and manufacturing organization and rebranded as Adare Phama Solutions, headquartered in Lawrenceville, New Jersey.

<span class="mw-page-title-main">Pharmacia & Upjohn</span> Global pharmaceutical company

Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid.

<span class="mw-page-title-main">Nasdaq, Inc.</span> American multinational financial services corporation

Nasdaq, Inc. is an American multinational financial services corporation that owns and operates three stock exchanges in the United States: the namesake Nasdaq stock exchange, the Philadelphia Stock Exchange, and the Boston Stock Exchange, and seven European stock exchanges: Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, and Nasdaq Vilnius. It is headquartered in New York City, and its president and chief executive officer is Adena Friedman.

<span class="mw-page-title-main">Scandic Hotels</span> Swedish hotel chain

Scandic Hotels is a hotel chain headquartered in Stockholm, Sweden, with its main operations in the Nordic countries. Alongside hotels in Sweden, Norway, Finland and Denmark, the company also has a presence in Germany and Poland. As of 31 December 2018, the company has 11,560 employees and operates 283 hotels with 51,693 guest rooms. The company has stated that is an ecologically sustainable business since 1994.

<span class="mw-page-title-main">Thule Group</span> Swedish company

Thule Group AB is a Swedish company that owns brands related to outdoor and transportation products. These include cargo carriers for automobiles and other outdoor and storage products, with 4,700 points of sale in 136 countries worldwide.

Pharmadule was a Swedish company, specialized in design and construction of modular pharmaceutical manufacturing facilities in the same fashion as modular homes nowadays are being built. The unique idea came from its founder, Clas Wallenborg, in 1986 as a result of several troublesome facility constructions abroad for Pharmacia.

<span class="mw-page-title-main">Swedish Orphan Biovitrum</span> Swedish pharmaceutical company

Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.

<span class="mw-page-title-main">Sigma AB</span>

Sigma AB is a group of companies carrying out consultancy operations within IT, information logistics, engineering services, technical R&D, industry and social structure.

<span class="mw-page-title-main">IFS AB</span> Software company

IFS AB is a multinational enterprise software company headquartered in Linköping, Sweden. The company develops and delivers enterprise software for customers worldwide who manufacture and distribute goods, maintain assets, and manage service-focused operations. IFS has over 5,000 employees that support thousands of customers worldwide from a network of local offices and a growing ecosystem of partners.

<span class="mw-page-title-main">BTS Group</span> BTS group

BTS Group AB (BTS) is a global strategy implementation consulting firm founded in 1986. The company provides strategy alignment and execution consulting services and designs customized business simulations, digital technology, and assessments to develop business acumen, leadership, and sales capabilities.

Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. Meda imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are currently sold in more than 150 countries.

Refaat El-Sayed is a businessman of Egyptian and Swedish nationality. At the beginning of the 1980s, he took command of a small biotech company, Fermenta, which he quickly turned into one of the success stories of the Stockholm stock exchange. El-Sayed soon became Sweden's richest man, and made the fortune of his employees and shareholders. A charismatic leader, he was a favourite of the media, and in December 1985 he was named "Swede of the year" by the TV news program Rapport. The following month, Fermenta announced a partnership with Swedish industrial giant Volvo. El-Sayed was at the peak of his fame.

LeoVegas AB is a Swedish mobile gaming company and provider of online casino and sports betting services such as table games, video slots, progressive jackpots, video poker and live betting to a number of international markets. LeoVegas Gaming Ltd. is a subsidiary of MGM resorts international.

Embracer Group AB is a Swedish video game and media holding company based in Karlstad. As of September 2023, Embracer Group has twelve operative groups as its direct subsidiaries: Amplifier Game Invest, Asmodee, CDE Entertainment, Coffee Stain Holding, Dark Horse Media, DECA Games, Easybrain, Embracer Freemode including its subdivision Middle-earth Enterprises, Gearbox Entertainment, Plaion, Saber Interactive, and THQ Nordic. Each group has its own operations, subsidiaries and development studios.

Pandox AB is a hotel property company. The company engages in ownership and management of hotel property. Pandox leases its hotel properties to hotel operators or runs hotel operations in its own hotel properties. Pandox owns approximately 150 hotel properties with a total of 35,000 hotel rooms. The hotel properties are located in 15 European countries.

References

  1. ↑ "The Recipharm story". Recipharm. Archived from the original on 2016-08-16. Retrieved 17 March 2017– via Internet Archive.
  2. ↑ Nyström, Anna (2 May 2005). "Läkemedelsföretag med miljöprofil" [Pharmaceutical company with an environmental profile]. Miljö & Utveckling (in Swedish). Retrieved 10 September 2022.
  3. ↑ "Meda acquires Recip" (PDF) (Press release). Meda AB. Retrieved 10 September 2022.
  4. ↑ "Recipharm". Recipharm. 2014. Retrieved 17 March 2020– via NASDAQ.
  5. 1 2 "Recipharm". Current Portfolio. EQT. 2021. Retrieved 10 September 2022.
  6. ↑ "Recipharm International Environmental Award".
  7. ↑ "Lars Backsell och Thomas Eldered, Recipharm, från Jordbro är två av Sveriges främsta entreprenörer". News Powered by Cision (in Swedish). Retrieved 2020-03-17.
  8. ↑ "Founders of Recipharm awarded enterprise medal". Nordic Life Science – the leading Nordic life science news service. 2014-04-11. Retrieved 2020-03-17.
  9. ↑ "Recipharm AB: Recipharm wins SwedenBIO Award - Analysguiden". Aktiespararna (in Swedish). 5 June 2015. Retrieved 2020-03-17.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.